Tomonari Awaya

1.8k citations

55 papers · 1.1k indexed · h-index 17

Co-authors: Tatsutoshi Nakahata Toshio Heike Takeo Kato Masatoshi Hagiwara Hidehiro Toh Masato Ono Takashi Miyata Akira Niwa
Topics: Genetics and Neurodevelopmental Disorders (8 papers)Muscle Physiology and Disorders (7 papers)Autism Spectrum Disorder Research (7 papers)
Cited by: Developmental Neuroscience Molecular Biology Genetics
Journals: Proceedings of the National Academy of Sciences Nature Communications PLoS ONE
Partner nations: Japan United States Germany

In The Last Decade

Tomonari Awaya

53 papers receiving 1.1k citations

Peers

Countries citing papers authored by Tomonari Awaya

Since Specialization

Citations

This map shows the geographic impact of Tomonari Awaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomonari Awaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomonari Awaya more than expected).

Fields of papers citing papers by Tomonari Awaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomonari Awaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomonari Awaya. The network helps show where Tomonari Awaya may publish in the future.

Co-authorship network of co-authors of Tomonari Awaya

This figure shows the co-authorship network connecting the top 25 collaborators of Tomonari Awaya. A scholar is included among the top collaborators of Tomonari Awaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomonari Awaya. Tomonari Awaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PDIVAS: Pathogenicity predictor for Deep-Intronic Variants causing Aberrant Splicing 2023 ·BMC Genomics ·(unknown),Kei Iida,Masahiko Ajiro,Tomonari Awaya,Mamiko Yamada,Kenjiro Kosaki,Masatoshi Hagiwara	12
2	Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC 2023 ·iScience ·(unknown),Ryuta Mikawa,(unknown),Yukiko Okuno,Tomonari Awaya,Yuki Yamamoto,Senye Takahashi,(unknown),Mitsujiro Osawa,Yasuhiro Setoguchi,Megumu K. Saito,Shinji Abe,Toyohiro Hirai,Shimpei Gotoh,Masatoshi Hagiwara	2
3	Branchpoints as potential targets of exon-skipping therapies for genetic disorders 2023 ·Molecular Therapy — Nucleic Acids ·(unknown),(unknown),Tomonari Awaya,(unknown),(unknown),Y Sako,Megumu Ogawa,Masashi Ogasawara,S. Noguchi,Yu‐ichi Goto,Ryōsuke Takahashi,Ichizo Nishino,Masatoshi Hagiwara	6
4	Comparison of the Social Responsiveness Scale-2 among Individuals with Autism Spectrum Disorder and Williams Syndrome in Japan 2022 ·Journal of Autism and Developmental Disorders ·Masahiro Hirai,(unknown),Takeo Kato,Takahiro Ikeda,Yoko Hakuno,(unknown),(unknown),Tomonari Awaya,Shin Okazaki,Toshihiro Kato,Yasuko Funabiki,Toshiya Murai,Toshio Heike,Masatoshi Hagiwara,Takanori Yamagata,Kiyotaka Tomiwa,Ryo Kimura	3
5	Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia 2021 ·Nature Communications ·Masahiko Ajiro,Tomonari Awaya,(unknown),Kei Iida,(unknown),Nobuo Tanaka,(unknown),Shingo Matsushima,(unknown),(unknown),Lorenz Studer,Adrian R. Krainer,Masatoshi Hagiwara	25
6	Generation of two human induced pluripotent stem cell lines derived from two X-linked adrenoleukodystrophy patients with ABCD1 mutations 2021 ·Stem Cell Research ·(unknown),Tomonari Awaya,Mami Matsuo‐Takasaki,Miho Takami,(unknown),Jingyue Li,(unknown),(unknown),(unknown),Jun Inoue,Michiya Noguchi,Yukio Nakamura,Isao Asaka,Kazunori Akimoto,Megumu K. Saito,Yohei Hayashi	4
7	Integrated DNA methylation analysis reveals a potential role for ANKRD30B in Williams syndrome 2020 ·Neuropsychopharmacology ·Ryo Kimura,Roy Lardenoije,Kiyotaka Tomiwa,Yasuko Funabiki,(unknown),Shiho Suzuki,Tomonari Awaya,Takeo Kato,Shin Okazaki,Toshiya Murai,Toshio Heike,Bart P. F. Rutten,Masatoshi Hagiwara	9
8	Dysregulation of the oxytocin receptor gene in Williams syndrome 2020 ·Psychoneuroendocrinology ·Ryo Kimura,Kiyotaka Tomiwa,Ryo Inoüe,Shiho Suzuki,(unknown),Tomonari Awaya,Takeo Kato,Shin Okazaki,Toshio Heike,Masatoshi Hagiwara	8
9	MicroRNA profiling in adults with high-functioning autism spectrum disorder 2019 ·Molecular Brain ·(unknown),Ryo Kimura,Yasuko Funabiki,Tomonari Awaya,Toshiya Murai,Masatoshi Hagiwara	32
10	An epigenetic biomarker for adult high-functioning autism spectrum disorder 2019 ·Scientific Reports ·Ryo Kimura,(unknown),Yasuko Funabiki,Shiho Suzuki,Tomonari Awaya,Toshiya Murai,Masatoshi Hagiwara	26
11	Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2019 ·Journal of Human Genetics ·(unknown),(unknown),Bumpei Samata,Tomonari Awaya,Jun Takahashi,Masatoshi Hagiwara,Tatsutoshi Nakahata,Megumu K. Saito	4
12	Integrative network analysis reveals biological pathways associated with Williams syndrome 2018 ·Journal of Child Psychology and Psychiatry ·Ryo Kimura,Vivek Swarup,Kiyotaka Tomiwa,Michael J. Gandal,Neelroop Parikshak,Yasuko Funabiki,(unknown),Tomonari Awaya,Takeo Kato,Kei Iida,Shin Okazaki,(unknown),Toshihiro Kato,Toshiya Murai,Toshio Heike,Daniel H. Geschwind,Masatoshi Hagiwara	21
13	A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells 2017 ·Scientific Reports ·Takeshi Yoshida,Tomonari Awaya,(unknown),Ryo Kimura,Shigemi Kimura,Takumi Era,Toshio Heike,Hidetoshi Sakurai	42
14	Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice 2017 ·Proceedings of the National Academy of Sciences ·Akiko Nakano-Kobayashi,Tomonari Awaya,Isao Kii,Yuto Sumida,Yukiko Okuno,Suguru Yoshida,(unknown),Haruhisa Inoue,Takamitsu Hosoya,Masatoshi Hagiwara	61
15	Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells 2015 ·Scientific Reports ·Emi Shoji,Hidetoshi Sakurai,(unknown),Tatsutoshi Nakahata,Toshio Heike,Tomonari Awaya,Nobuharu Fujii,Yasuko Manabe,Masafumi Matsuo,Atsuko Sehara‐Fujisawa	90
16	Hypergonadotropic hypogonadism and hypersegmented neutrophils in a patient with ataxia‐telangiectasia‐like disorder: Potential diagnostic clues? 2014 ·American Journal of Medical Genetics Part A ·Takeshi Yoshida,Tomonari Awaya,Minoru Shibata,Takeo Kato,Hironao Numabe,Junya Kobayashi,(unknown),Toshio Heike	9
17	Derivation of Engraftable Myogenic Precursors from Murine ES/iPS cells and Generation of Disease-specific iPS cells from Patients with Duchenne Muscular dystrophy (DMD) and Other Diseases 2010 ·Rinsho Shinkeigaku ·Tatsutoshi Nakahata,Tomonari Awaya,(unknown),(unknown),Akira Niwa,So‐ichiro Fukada,Shin’ichi Takeda,Shinya Yamanaka,Toshio Heike	3
18	Successful treatment of refractory donor lymphocyte infusion‐induced immune‐mediated pancytopenia with rituximab 2009 ·Pediatric Blood & Cancer ·Itaru Kato,Katsutsugu Umeda,Tomonari Awaya,Yoshihiro Yui,Akira Niwa,Hisanori Fujino,Hiroshi Matsubara,Kenichiro Watanabe,Toshio Heike,Naoto Adachi,Fumio Endo,Tomoyuki Mizukami,Hiroyuki Nunoi,Tatsutoshi Nakahata,Souichi Adachi	1
19	A combination therapy of whole lung lavage and GM‐CSF inhalation in pulmonary alveolar proteinosis 2008 ·Pediatric Pulmonology ·(unknown),Etsuro Yamaguchi,Hiroatsu Agata,(unknown),Toru Komatsu,(unknown),Kenji Baba,Tomonari Awaya,Ryuta Nishikomori,Masahito Tsurusawa,Koh Nakata	31
20	Cefoselis, a ?-lactam antibiotic, easily penetrates the blood-brain barrier and causes seizure independently by glutamate release 2004 ·Journal of Neural Transmission ·Kohei Ohtaki,Keiko Matsubara,(unknown),Keiko Shimizu,Tomonari Awaya,Manabu Suno,(unknown),Nobumasa Hayase,Hiroshi Shiono	11

About Tomonari Awaya

Tomonari Awaya is a scholar working on Chemical Health and Safety, Developmental Neuroscience and Clinical Biochemistry, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (8 papers), Muscle Physiology and Disorders (7 papers) and Autism Spectrum Disorder Research (7 papers). The work is most often cited by research in Developmental Neuroscience (46 citations), Molecular Biology (691 citations) and Genetics (105 citations). Tomonari Awaya has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Tatsutoshi Nakahata, Toshio Heike, Takeo Kato, Masatoshi Hagiwara, Hidehiro Toh, Masato Ono, Takashi Miyata, Akira Niwa, Katsutsugu Umeda and Hsi Chang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact